NO20043733L - Aryl-5-tio-Β-D-glukopyranosid-derivater og legemidler for diabetes inneholdende de samme - Google Patents

Aryl-5-tio-Β-D-glukopyranosid-derivater og legemidler for diabetes inneholdende de samme

Info

Publication number: NO20043733L
Authority: NO; Norway
Prior art keywords: thio; drugs; aryl; same; diabetes containing
Prior art date: 2002-08-09

Application number

NO20043733A

Other languages

English (en)

Inventor

Masakazu Sato

Hiroyuki Kakinuma

Hajime Asanuma

Original Assignee

Taisho Pharmaceutical Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-08-09

Filing date

2004-09-07

Publication date

2004-10-20

2004-09-07 Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd

2004-10-20 Publication of NO20043733L publication Critical patent/NO20043733L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Diabetes (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Cardiology (AREA)
Obesity (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Hospice & Palliative Care (AREA)
Oncology (AREA)
Emergency Medicine (AREA)
Dermatology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Communicable Diseases (AREA)
Ophthalmology & Optometry (AREA)
Child & Adolescent Psychology (AREA)
Vascular Medicine (AREA)

NO20043733A 2002-08-09 2004-09-07 Aryl-5-tio-Β-D-glukopyranosid-derivater og legemidler for diabetes inneholdende de samme NO20043733L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2002233015		2002-08-09
JP2003097839		2003-04-01
PCT/JP2003/010160 WO2004014931A1 (ja)	2002-08-09	2003-08-08	アリール５−チオ−β−Ｄ−グルコピラノシド誘導体及びそれを含有する糖尿病治療薬

Publications (1)

Publication Number	Publication Date
NO20043733L true NO20043733L (no)	2004-10-20

Family

ID=31719867

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NO20043733A NO20043733L (no)	2002-08-09	2004-09-07	Aryl-5-tio-Β-D-glukopyranosid-derivater og legemidler for diabetes inneholdende de samme
NO20050650A NO20050650L (no)	2002-08-09	2005-02-07	Fremgangsmate for selektiv fremstilling av aryl-5-tio- -D-aldoheksopyranosider

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
NO20050650A NO20050650L (no)	2002-08-09	2005-02-07	Fremgangsmate for selektiv fremstilling av aryl-5-tio- -D-aldoheksopyranosider

Country Status (18)

Country	Link
US (2)	US7250522B2 (no)
EP (2)	EP1541578A1 (no)
JP (2)	JPWO2004014930A1 (no)
KR (2)	KR20050056194A (no)
CN (2)	CN1312165C (no)
AU (2)	AU2003254904A1 (no)
BR (1)	BR0310006A (no)
CA (2)	CA2478889A1 (no)
HR (1)	HRP20040814A2 (no)
MX (2)	MXPA05000725A (no)
NO (2)	NO20043733L (no)
NZ (1)	NZ535229A (no)
PL (2)	PL375298A1 (no)
RU (1)	RU2322449C2 (no)
TW (2)	TW200409778A (no)
UA (1)	UA77300C2 (no)
WO (2)	WO2004014931A1 (no)
ZA (1)	ZA200407187B (no)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1020944C (zh)	1990-01-30	1993-05-26	阿图尔-费希尔股份公司费希尔厂	紧固件
AU2003301900A1 (en) *	2002-11-13	2004-06-03	Fumie Sato	Antipruritic drug
WO2004089966A1 (ja) *	2003-04-01	2004-10-21	Taisho Pharmaceutical Co., Ltd.	選択的なヘテロアリール５－チオ－β－Ｄ－アルドヘキソピラノシドの製造法
US8785403B2 (en)	2003-08-01	2014-07-22	Mitsubishi Tanabe Pharma Corporation	Glucopyranoside compound
CN103214471B (zh)	2003-08-01	2018-02-06	田边三菱制药株式会社	具有钠依赖型葡萄糖转运体抑制活性的化合物的制备方法
TW200606129A (en) *	2004-07-26	2006-02-16	Chugai Pharmaceutical Co Ltd	Novel cyclohexane derivative, its prodrug, its salt and diabetic therapeutic agent containing the same
CN101010276B (zh) *	2004-07-26	2011-01-12	中外制药株式会社	环己烷衍生物、其前体药物及其盐、以及含有它的糖尿病治疗药
TW200637839A (en)	2005-01-07	2006-11-01	Taisho Pharmaceutical Co Ltd	1-thio-d-glucitol derivatives
TW200637869A (en)	2005-01-28	2006-11-01	Chugai Pharmaceutical Co Ltd	The spiroketal derivatives and the use as therapeutical agent for diabetes of the same
JP5073948B2 (ja) *	2005-01-31	2012-11-14	田辺三菱製薬株式会社	医薬組成物
TWI365186B (en)	2005-01-31	2012-06-01	Mitsubishi Tanabe Pharma Corp	Indole derivatives
JP2009167104A (ja) *	2006-05-02	2009-07-30	Taisho Pharmaceutical Co Ltd	フェニル５−チオグリコシド化合物
EP1854806A1 (en) *	2006-05-02	2007-11-14	MPG Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.	Thioglycosides as pharmaceutically active agents
PE20080251A1 (es)	2006-05-04	2008-04-25	Boehringer Ingelheim Int	Usos de inhibidores de dpp iv
JP5230613B2 (ja) *	2006-05-23	2013-07-10	テラコス・インコーポレイテッド	グルコース輸送体阻害剤およびその使用方法
JP5152519B2 (ja) *	2006-06-29	2013-02-27	大正製薬株式会社	Ｃ−フェニル１−チオグルシト−ル化合物
TWI418556B (zh)	2006-07-27	2013-12-11	Mitsubishi Tanabe Pharma Corp	吲哚衍生物
FR2906247B1 (fr) *	2006-09-27	2008-12-26	Fournier S A Sa Lab	Nouveaux derives de 5-thioxylopyranose
TWI499414B (zh)	2006-09-29	2015-09-11	Lexicon Pharmaceuticals Inc	鈉與葡萄糖第２型共同運輸體（ｃｏ-ｔｒａｎｓｐｏｒｔｅｒ２）的抑制物與其應用方法
AU2007307544A1 (en)	2006-10-13	2008-04-17	Chugai Seiyaku Kabushiki Kaisha	Thioglucose spiroketal derivative and use thereof as therapeutic agent for diabetes
AU2007329490B2 (en)	2006-12-04	2012-05-17	Janssen Pharmaceutica N.V.	Thienyl-containing glycopyranosyl derivatives as antidiabetics
UY30730A1 (es)	2006-12-04	2008-07-03	Mitsubishi Tanabe Pharma Corp	Forma cristalina del hemihidrato de 1-(b (beta)-d-glucopiranosil) -4-metil-3-[5-(4-fluorofenil) -2-tienilmetil]benceno
CN101611023A (zh)	2006-12-14	2009-12-23	大正制药株式会社	1－苯基1－硫代－d－山梨醇衍生物
US7795228B2 (en) *	2006-12-28	2010-09-14	Theracos, Inc.	Spiroheterocyclic glycosides and methods of use
WO2008109591A1 (en) *	2007-03-08	2008-09-12	Lexicon Pharmaceuticals, Inc.	Phlorizin analogs as inhibitors of sodium glucose co-transporter 2
US20070172525A1 (en) *	2007-03-15	2007-07-26	Ramesh Sesha	Anti-diabetic combinations
US20080064701A1 (en) *	2007-04-24	2008-03-13	Ramesh Sesha	Anti-diabetic combinations
RU2492175C2 (ru) *	2007-04-02	2013-09-10	Теракос, Инк.	Бензиловые производные гликозидов и способы их применения
ATE530558T1 (de) *	2007-07-26	2011-11-15	Lexicon Pharmaceuticals Inc	Verfahren und verbindungen zur herstellung von natriumglucose-co-transporter-2-hemmern
NO2187742T3 (no)	2007-08-23	2018-03-24
SI2200606T1 (sl)	2007-09-10	2017-12-29	Janssen Pharmaceutica N.V.	Postopek za pripravo spojin, uporabnih kot inhibitorjev SGLT
UA101004C2 (en)	2007-12-13	2013-02-25	Теракос, Инк.	Derivatives of benzylphenylcyclohexane and use thereof
CL2008003653A1 (es)	2008-01-17	2010-03-05	Mitsubishi Tanabe Pharma Corp	Uso de un inhibidor de sglt derivado de glucopiranosilo y un inhibidor de dppiv seleccionado para tratar la diabetes; y composicion farmaceutica.
US8551524B2 (en) *	2008-03-14	2013-10-08	Iycus, Llc	Anti-diabetic combinations
BRPI0916769A2 (pt)	2008-07-15	2017-09-26	Theracos Inc	derivados de benzilbenzeno deuterados e métodos de uso
HUE029970T2 (en) *	2008-08-22	2017-04-28	Theracos Sub Llc	Processes for the preparation of sglt2 inhibitors
AU2009286380B2 (en) *	2008-08-28	2011-09-15	Pfizer Inc.	Dioxa-bicyclo[3.2.1.]octane-2,3,4-triol derivatives
US9056850B2 (en)	2008-10-17	2015-06-16	Janssen Pharmaceutica N.V.	Process for the preparation of compounds useful as inhibitors of SGLT
MX344264B (es)	2009-02-13	2016-12-09	Boehringer Ingelheim Int Gmbh *	Inhibidor de sglt-2 para el tratamiento de diabetes mellitus tipo 1, diabetes mellitus tipo 2, tolerancia deteriorada a la glucosa o hiperglucemia.
US20110009347A1 (en)	2009-07-08	2011-01-13	Yin Liang	Combination therapy for the treatment of diabetes
ES2416459T3 (es)	2009-07-10	2013-08-01	Janssen Pharmaceutica, N.V.	Procedimiento de cristalización para 1-( -D-glucopiranosil)-4-metil-3-[5-(4-fluorofenil)-2-tienilmetil]benceno
ME02634B (me) *	2009-10-14	2017-06-20	Janssen Pharmaceutica Nv	Proces za pripremu jedinjenja koja su korisna kao inhibitori sglt2
JP5696156B2 (ja)	2009-11-02	2015-04-08	ファイザー・インク	ジオキサ−ビシクロ［３．２．１］オクタン−２，３，４−トリオール誘導体
ES2596291T3 (es)	2010-05-11	2017-01-05	Janssen Pharmaceutica, N.V.	Formulaciones farmacéuticas que comprenden derivados de 1-(beta-d-glucopiranosil)-2-tienilmetilbenceno como inhibidores de sglt
WO2011153712A1 (en)	2010-06-12	2011-12-15	Theracos, Inc.	Crystalline form of benzylbenzene sglt2 inhibitor
KR101913587B1 (ko)	2011-04-13	2018-10-31	얀센 파마슈티카 엔.브이.	Sglt2의 억제제로서 유용한 화합물의 제조 방법
TWI542596B (zh)	2011-05-09	2016-07-21	健生藥品公司	（２ｓ,３ｒ,４ｒ,５ｓ,６ｒ）－２－（３－（（５－（４－氟苯基）噻吩－２－基）甲基）－４－甲基苯基）－６－（羥甲基）四氫－２ｈ－哌喃－３,４,５－三醇之ｌ－脯胺酸及檸檬酸共晶體
NZ701245A (en)	2012-03-28	2015-12-24	Fujifilm Corp	Salt of 1-(2-deoxy-2-fluoro-4-thio-β-d-arabinofuranosyl)cytosine
US9193751B2 (en)	2012-04-10	2015-11-24	Theracos, Inc.	Process for the preparation of benzylbenzene SGLT2 inhibitors
EP2883866B1 (en)	2012-08-13	2019-02-27	FUJIFILM Corporation	INTERMEDIATE FOR SYNTHESIS OF 1-(2-DEOXY-2-FLUORO-4-THIO-beta-D-ARABINOFURANOSYL) CYTOSINE, INTERMEDIATE FOR SYNTHESIS OF THIONUCLEOSIDE, AND METHODS FOR PRODUCING THESE INTERMEDIATES
US10202356B2 (en)	2013-03-14	2019-02-12	Tolero Pharmaceuticals, Inc.	JAK2 and ALK2 inhibitors and methods for their use
CA2812519A1 (en)	2013-04-05	2014-10-05	Boehringer Ingelheim International Gmbh	Pharmaceutical composition, methods for treating and uses thereof
HK1215398A1 (zh)	2013-04-05	2016-08-26	勃林格殷格翰国际有限公司	依帕列净的治疗用途
US20140303097A1 (en)	2013-04-05	2014-10-09	Boehringer Ingelheim International Gmbh	Pharmaceutical composition, methods for treating and uses thereof
US11813275B2 (en)	2013-04-05	2023-11-14	Boehringer Ingelheim International Gmbh	Pharmaceutical composition, methods for treating and uses thereof
PT2986304T (pt)	2013-04-18	2022-02-25	Boehringer Ingelheim Int	Composição farmacêutica, métodos para o tratamento e suas utilizações
CN105611920B (zh)	2013-10-12	2021-07-16	泰拉科斯萨普有限责任公司	羟基-二苯甲烷衍生物的制备
WO2015125781A1 (ja)	2014-02-18	2015-08-27	富士フイルム株式会社	チオラン骨格型糖化合物の製造方法およびチオラン骨格型糖化合物
JP6204223B2 (ja) *	2014-02-19	2017-09-27	富士フイルム株式会社	チオピラノース化合物等の製造方法
TWI678373B (zh)	2014-10-31	2019-12-01	日商富士軟片股份有限公司	硫代核苷衍生物或其鹽及醫藥組合物
US20170071970A1 (en)	2015-09-15	2017-03-16	Janssen Pharmaceutica Nv	Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disorders
KR102198656B1 (ko)	2016-08-31	2021-01-05	후지필름 가부시키가이샤	항종양제, 항종양 효과 증강제 및 항종양용 키트
MA46742A (fr)	2016-11-10	2019-09-18	Boehringer Ingelheim Int	Composition pharmaceutique, méthodes de traitement et leurs utilisations
CA3089728C (en)	2018-01-29	2023-01-10	Fujifilm Corporation	Antitumor agent for biliary tract cancer and method for treating biliary tract cancer
JP2021530554A (ja)	2018-07-26	2021-11-11	スミトモダイニッポンファーマオンコロジー，インコーポレイテッド	異常なａｃｖｒ１発現を伴う疾患を処置するための方法およびそこで使用するためのａｃｖｒ１阻害剤

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2660313B1 (fr) *	1990-04-02	1992-07-03	Fournier Ind & Sante	Nouveau sulfonyl-phenyl-betha-d-thioxylosides, leur procede de preparation et leur utilisation en therapeutique.
ES2176600T3 (es) *	1996-12-26	2002-12-01	Tanabe Seiyaku Co	Derivado de la propiofenona y procedimientos para su preparacion.
JP3055135B2 (ja) *	1996-12-26	2000-06-26	田辺製薬株式会社	プロピオフェノン誘導体及びその製法
DK1213296T3 (da)	1999-08-31	2004-08-16	Kissei Pharmaceutical	Glucopyranosyloxpyrazolderivater, lægemidler indeholdende samme samt mellemprodukter til fremstilling heraf
FR2801055B1 (fr) *	1999-11-17	2002-02-08	Fournier Ind & Sante	Derives de beta-d-5-thioxylose, procede de preparation et utilisation en therapeutique
EP1270584B1 (en) *	2000-03-17	2005-12-07	Kissei Pharmaceutical Co., Ltd.	Glucopyranosyloxy benzylbenzene derivatives, medicinal compositions containing the same and intermediates for the preparation of the derivatives
US6555519B2 (en) *	2000-03-30	2003-04-29	Bristol-Myers Squibb Company	O-glucosylated benzamide SGLT2 inhibitors and method
US6683056B2 (en) *	2000-03-30	2004-01-27	Bristol-Myers Squibb Company	O-aryl glucoside SGLT2 inhibitors and method
JP2003534176A (ja)	2000-05-20	2003-11-18	テサ・アクチエンゲゼルシヤフト	接着テープの被覆材料の支持片としての高密度の紙支持材の使用
SK287811B6 (sk) *	2000-09-29	2011-10-04	Kissei Pharmaceutical Co., Ltd	Glukopyranozyloxybenzylbenzénový derivát, farmaceutická kompozícia a ľudský SGLT2-inhibítor tento derivát obsahujúci a použitie tohto derivátu
WO2002036602A1 (en)	2000-11-02	2002-05-10	Ajinomoto Co., Inc.	Novel pyrazole derivatives and diabetes remedies containing the same
WO2002053573A1 (en) *	2000-12-28	2002-07-11	Kissei Pharmaceutical Co., Ltd.	Glucopyranosyloxypyrazole derivatives and use thereof in medicines
JP4399254B2 (ja)	2001-06-20	2010-01-13	キッセイ薬品工業株式会社	含窒素複素環誘導体、それを含有する医薬組成物、その医薬用途およびその製造中間体
WO2004089966A1 (ja) *	2003-04-01	2004-10-21	Taisho Pharmaceutical Co., Ltd.	選択的なヘテロアリール５－チオ－β－Ｄ－アルドヘキソピラノシドの製造法
CN1761676A (zh) *	2003-04-01	2006-04-19	大正制药株式会社	杂芳基5－硫代－β－D－吡喃葡糖苷衍生物及含有该衍生物的糖尿病治疗药

2003
- 2003-08-08 WO PCT/JP2003/010160 patent/WO2004014931A1/ja not_active Ceased
- 2003-08-08 WO PCT/JP2003/010159 patent/WO2004014930A1/ja not_active Ceased
- 2003-08-08 HR HR20040814A patent/HRP20040814A2/hr not_active Application Discontinuation
- 2003-08-08 CN CNB038056402A patent/CN1312165C/zh not_active Expired - Fee Related
- 2003-08-08 CA CA002478889A patent/CA2478889A1/en not_active Abandoned
- 2003-08-08 PL PL03375298A patent/PL375298A1/xx not_active Application Discontinuation
- 2003-08-08 US US10/521,809 patent/US7250522B2/en not_active Expired - Fee Related
- 2003-08-08 EP EP03784622A patent/EP1541578A1/en not_active Withdrawn
- 2003-08-08 KR KR1020057002280A patent/KR20050056194A/ko not_active Ceased
- 2003-08-08 PL PL03372865A patent/PL372865A1/xx not_active Application Discontinuation
- 2003-08-08 US US10/518,788 patent/US7414072B2/en not_active Expired - Fee Related
- 2003-08-08 TW TW092121895A patent/TW200409778A/zh unknown
- 2003-08-08 JP JP2004527382A patent/JPWO2004014930A1/ja not_active Ceased
- 2003-08-08 MX MXPA05000725A patent/MXPA05000725A/es active IP Right Grant
- 2003-08-08 CN CNB038191423A patent/CN100341885C/zh not_active Expired - Fee Related
- 2003-08-08 AU AU2003254904A patent/AU2003254904A1/en not_active Abandoned
- 2003-08-08 AU AU2003254903A patent/AU2003254903B9/en not_active Ceased
- 2003-08-08 CA CA002493491A patent/CA2493491A1/en not_active Abandoned
- 2003-08-08 KR KR1020047014192A patent/KR100588457B1/ko not_active Expired - Fee Related
- 2003-08-08 TW TW092121886A patent/TWI274055B/zh not_active IP Right Cessation
- 2003-08-08 UA UA20041210074A patent/UA77300C2/uk unknown
- 2003-08-08 NZ NZ535229A patent/NZ535229A/en unknown
- 2003-08-08 EP EP03784623A patent/EP1528066A4/en not_active Withdrawn
- 2003-08-08 MX MXPA04009265A patent/MXPA04009265A/es active IP Right Grant
- 2003-08-08 JP JP2004527383A patent/JP3813160B2/ja not_active Expired - Fee Related
- 2003-08-08 RU RU2004135914/04A patent/RU2322449C2/ru not_active IP Right Cessation
- 2003-08-08 BR BR0310006-5A patent/BR0310006A/pt not_active IP Right Cessation
2004
- 2004-09-07 NO NO20043733A patent/NO20043733L/no not_active Application Discontinuation
- 2004-09-08 ZA ZA200407187A patent/ZA200407187B/en unknown
2005
- 2005-02-07 NO NO20050650A patent/NO20050650L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
KR100588457B1 (ko)	2006-06-12
MXPA05000725A (es)	2005-04-08
US7414072B2 (en)	2008-08-19
HK1077582A1 (en)	2006-02-17
WO2004014931A1 (ja)	2004-02-19
US20050209309A1 (en)	2005-09-22
CN1312165C (zh)	2007-04-25
PL372865A1 (en)	2005-08-08
AU2003254903B2 (en)	2008-07-31
NO20050650L (no)	2005-03-04
WO2004014930A1 (ja)	2004-02-19
EP1541578A1 (en)	2005-06-15
JPWO2004014931A1 (ja)	2005-12-02
AU2003254903B9 (en)	2008-08-21
EP1528066A4 (en)	2007-05-02
HRP20040814A2 (en)	2005-06-30
CN1639180A (zh)	2005-07-13
MXPA04009265A (es)	2005-01-25
KR20050056194A (ko)	2005-06-14
CA2493491A1 (en)	2004-02-19
US7250522B2 (en)	2007-07-31
EP1528066A1 (en)	2005-05-04
PL375298A1 (en)	2005-11-28
TWI274055B (en)	2007-02-21
CN1675233A (zh)	2005-09-28
TW200409778A (en)	2004-06-16
CA2478889A1 (en)	2004-02-19
KR20050018642A (ko)	2005-02-23
RU2004135914A (ru)	2005-05-10
HK1079532A1 (en)	2006-04-07
US20050256317A1 (en)	2005-11-17
UA77300C2 (en)	2006-11-15
BR0310006A (pt)	2005-02-15
AU2003254903A1 (en)	2004-02-25
AU2003254904A1 (en)	2004-02-25
NZ535229A (en)	2006-05-26
CN100341885C (zh)	2007-10-10
RU2322449C2 (ru)	2008-04-20
JP3813160B2 (ja)	2006-08-23
ZA200407187B (en)	2006-02-22
JPWO2004014930A1 (ja)	2005-12-02
TW200406396A (en)	2004-05-01

Publication	Publication Date	Title
NO20043733L (no)	2004-10-20	Aryl-5-tio-Β-D-glukopyranosid-derivater og legemidler for diabetes inneholdende de samme
NO20052855D0 (no)	2005-06-13	Fosfonoksykinazolinderivater og farmasoytisk anvendelse derav.
DK1400518T3 (da)	2007-03-26	Heterocycliske forbindelser og lægemidler
PL375790A1 (en)	2005-12-12	Novel fluoroglycoside heterocyclic derivatives, pharmaceutical products containing said compounds and the use thereof
IS7946A (is)	2005-07-19	Lyf
NO20054681D0 (no)	2005-10-12	Farmasoytiske produkter
KR20050009999A (ko)	2005-01-26	약제학적 제제
ATE460418T1 (de)	2010-03-15	Heterocyclocarboxamidderivate
ATE450506T1 (de)	2009-12-15	Indol-3-schwefelderivate
ATE467631T1 (de)	2010-05-15	Chinuclidinamidderivate
DK1557415T3 (da)	2012-09-17	Heterocykliske forbindelser og antitumorlægemidler indeholdende samme som den aktive ingrediens
PT1467724E (pt)	2006-08-31	Composicao farmaceutica orodispersavel de agomelatina
EP1495774A4 (en)	2009-05-20	MEDICAL DEVICE
ATE335729T1 (de)	2006-09-15	3h-chinazoline -4-on derivaten
ATE423771T1 (de)	2009-03-15	Tetrahydrochinolinderivate
IS7798A (is)	2005-04-11	Efnasambönd, lyfjablöndur og aðferðir
ZA200602788B (en)	2008-01-30	Amidomethyl-substituted 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro-2H-chromen-6-YL-derivatives and drugs containing said compounds
GB0206505D0 (en)	2002-05-01	Pharmaceutical combination
DE50306277D1 (de)	2007-02-22	4-alkyl-/4-alkenyl-/4-alkinylmethyl/-1-arylcyclohexylamin-derivate
AU2003203233A1 (en)	2003-07-30	N-substituted sulfonamide derivatives and preventive or therapeutic drugs for diabetes containing the same
NO20053805D0 (no)	2005-08-12	Diarylmetylindenpiperidinderivater, framgangsmate for fremstilling derav, og anvendelse derav
PL373409A1 (en)	2005-08-22	Pharmaceutical combination
DK1593391T3 (da)	2013-11-11	Lægemiddel til degenererede båndskiver
AU2003248091A1 (en)	2004-02-09	Indole derivatives and drugs containing the same
GB0200612D0 (en)	2002-02-27	Drug testing

Legal Events

Date	Code	Title	Description
2009-06-15	FC2A	Withdrawal, rejection or dismissal of laid open patent application